mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |